PBPK‐led assessment of antimalarial drugs as candidates for Covid‐19: Simulating concentrations at the site of action to inform repurposing strategies

Documenti analoghi

• Concentration–Response Analysis of the Combination of Pyronaridine and Piperaquine on Corrected QT Interval From a Randomized, Double‐Blind, Placebo‐Controlled Study in Healthy Adults of African Sub‐Saharan Origin
  di: Mathieu Felices, et al.
  Pubblicazione: (2025)
• Physiologically‐Based Pharmacokinetic Modeling to Investigate Piperaquine Exposure in Pregnant Women Using an Individualized Profile Approach
  di: Sonia Khier, et al.
  Pubblicazione: (2026)
• Computational repurposing of oncology drugs through off‐target drug binding interactions from pharmacological databases
  di: Imogen R. Walpole, et al.
  Pubblicazione: (2024)
• Leveraging [ 18 F ]F‐Piflufolastat PET for PBPK Prediction of Tissue Distribution and Therapy Optimization in Prostate Cancer
  di: Suzanne van der Gaag, et al.
  Pubblicazione: (2026)
• Questions in self‐selection studies used in consumer research for nonprescription drug candidates: Limitations and recommendations
  di: Eric P. Brass, et al.
  Pubblicazione: (2024)